Damien Urban

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial

Roy S. Herbst, Yi‐Long Wu, Thomas John et al. · Journal of Clinical Oncology · 2023 · 350 citations · Full text

BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

Elizabeth Dudnik, Nir Peled, Hovav Nechushtan et al. · Journal of Thoracic Oncology · 2018 · 219 citations · Full text

Tumor Mutational Burden, Death Ligand 1, Medicine +9

Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

Benjamin Solomon, Richard J. Young, Mathias Bressel et al. · Cancer Immunology Research · 2018 · 126 citations · Full text

Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study

Jair Bar, Gal Markel, Teodor Gottfried et al. · European Journal of Cancer · 2019 · 102 citations

Thrombosis, Vascular Disease, Vasculitis +14

Frequency and prognostic significance of p16INK4A protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma

Richard J. Young, Damien Urban, Christopher Angel et al. · British Journal of Cancer · 2015 · 98 citations · Full text